Therapeutic Mechanism of Lapatinib Combined with Sulforaphane on Gastric Cancer

BACKGROUND: Lapatinib is a small-molecule tyrosine kinase inhibitor that plays important roles in cell proliferation and survival. Administration of lapatinib with capecitabine is an effective treatment for HER2-positive metastatic BC. However, the effects of lapatinib on gastric cancer (GC) remain...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Huixing, Li, Zheming, Liu, Xiaoxi, Dai, Shijie, Li, Shouye
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476239/
https://www.ncbi.nlm.nih.gov/pubmed/34589134
http://dx.doi.org/10.1155/2021/9933274

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8476239/
https://www.ncbi.nlm.nih.gov/pubmed/34589134
http://dx.doi.org/10.1155/2021/9933274

Ejemplares similares